Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis

Fig. 6

Bayesian ranking profiles of comparable treatments for efficacy and safety in the second-line setting. Profiles indicate the probability of each comparable treatment being ranked from first to last for OS, PFS, overall response rate and grade ≥ 3 adverse events. Ranking curves are described according to the Bayesian ranking results in Supplementary Table 2. Abbreviation: chemo, chemotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us